Mitotic kinesin inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S384000, C514S403000, C544S371000, C548S263200, C548S364400

Reexamination Certificate

active

07618971

ABSTRACT:
The present invention relates to dihydropyrazole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.

REFERENCES:
patent: 5134142 (1992-07-01), Matsuo et al.
patent: 5389648 (1995-02-01), Tsuboi et al.
patent: 5391560 (1995-02-01), Fuchs et al.
patent: 2005/0119484 (2005-06-01), Breslin et al.
patent: 2508934 (1975-09-01), None
patent: 0 537 580 (1992-05-01), None
patent: WO 01/32173 (2001-05-01), None
patent: WO 01/56993 (2001-08-01), None
patent: WO 02/46129 (2002-06-01), None
patent: WO 03/079973 (2003-10-01), None
patent: WO 2004/037171 (2004-05-01), None
Morissette et al. Advanced Drug Delivery Reviews 2004, 56, 275-300.
Vippagunta, Sudha R. “Crystalline Solids.” Advanced Drug Delivery Reviews 48(2001): 3-26.
S. K. Tahir, et al., Cancer Research, 61, pp. 5480-5485 (2001).
B. G. Szczepankiewicz, et al., J. Med. Chem., 44, pp. 4416-4430 (2001).
A. Attia, et al, Pharmazie 37, H.8, pp. 551-553 (1982).
F. Manna, et al., Bio. & Med. Chem. Ltrs, 12, pp. 3629-3633 (2002).
C. Safak, et al., J. Indian Chem. Soc., vol. 67, pp. 571-574 (1990).
U. Bauer, et al., Tetrahedron Letters, vol. 41, No. 15, pp. 2713-2717 (2000).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Mitotic kinesin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mitotic kinesin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mitotic kinesin inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4143024

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.